3-iodothyronamine inhibits apoptosis induced by myocardial ischemia reperfusion via the Akt/FoxO1 signaling pathway

Background This study investigated the potential effects of 3-iodothyronamine (T1AM) on myocardial ischemia reperfusion injury (MIRI) and the underlying molecular mechanisms. Methods A total of 16 adult male Sprague-Dawley rats were randomly divided into 4 groups and administered the following: control [60% dimethyl sulfoxide (DMSO) and 40% saline, pH 7.4], T1AM (25 mg/kg), T1AM (50 mg/kg), or T1AM (100 mg/kg). The rectal temperatures of the rats were measured at different time points. A further 30 adult male Sprague-Dawley rats were randomized and divided into the following 3 groups (n=10 in each group): sham operation, ischemia/reperfusion (I/R), and I/R + T1AM. In the I/R and I/R + T1AM groups, the left anterior descending (LAD) coronary artery of the rats were occluded for 0.5 hour to induce myocardial ischemia, followed by reperfusion for 3 hours in the I/R group. The electrocardiography (ECG), cardiac function, and 2,3,5-triphenyltetrazolium chloride (TTC) staining were examined in rats to evaluate the myocardial injury. The differences in the expression of apoptosis-related and Akt-FoxO1 signaling-related proteins were determined via Western blot. Results This work verified that T1AM reduced the body temperature of rats in a dose-dependent manner. Additionally, T1AM improved cardiac function and decreased the infarction size caused by MIRI. T1AM reduced the expression of biochemical parameters and apoptosis of myocardial cells. In addition, after treatment with T1AM, the expression of Glut1, pFoxO1 and Akt were reduced, while the expression of FoxO1 and PPARα were increased significantly. Conclusions Pretreatment of cardiomyocytes with T1AM inhibited apoptosis and protected against ischemia reperfusion injury via the Akt/FoxO1 signaling pathway.

[1]  Zhen Bian,et al.  Multi-omics analysis identifies FoxO1 as a regulator of macrophage function through metabolic reprogramming , 2020, Cell Death & Disease.

[2]  Yiming Wang,et al.  Comparative Transcriptome Analysis Reveals the Potential Cardiovascular Protective Targets of the Thyroid Hormone Metabolite 3-Iodothyronamine (3-T1AM) , 2020, BioMed research international.

[3]  G. Chiellini,et al.  3-Iodothyronamine Affects Thermogenic Substrates’ Mobilization in Brown Adipocytes , 2020, Biology.

[4]  Weipan Xu,et al.  TRAF5 protects against myocardial ischemia reperfusion injury via AKT signaling. , 2020, European journal of pharmacology.

[5]  Xingde Liu,et al.  Thyroid Hormone Metabolite 3-Iodothyronamine (T1AM) Alleviates Hypoxia/Reoxygenation-Induced Cardiac Myocyte Apoptosis via Akt/FoxO1 Pathway , 2020, Medical science monitor : international medical journal of experimental and clinical research.

[6]  A. Fernando,et al.  Deregulation of cell growth and apoptosis in UV-induced melanomagenesis. , 2020, Frontiers in bioscience.

[7]  S. Sestito,et al.  3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome? , 2020, International journal of molecular sciences.

[8]  S. Sestito,et al.  Endogenous 3-Iodothyronamine (T1AM) and Synthetic Thyronamine-Like Analog SG-2 Act as Novel Pleiotropic Neuroprotective Agents through the Modulation of SIRT6 , 2020, Molecules.

[9]  H. Wan,et al.  Overexpression of TGR5 alleviates myocardial ischemia/reperfusion injury via AKT/GSK-3β mediated inflammation and mitochondrial pathway , 2020, Bioscience reports.

[10]  Yundi Shi,et al.  FOXO1 inhibition prevents renal ischemia–reperfusion injury via cAMP‐response element binding protein/PPAR‐γ coactivator‐1α‐mediated mitochondrial biogenesis , 2020, British journal of pharmacology.

[11]  Jie Wang,et al.  Molecular machinery and interplay of apoptosis and autophagy in coronary heart disease. , 2019, Journal of molecular and cellular cardiology.

[12]  G. Rutigliano,et al.  Novel thyroid hormones , 2019, Endocrine.

[13]  H. Biebermann,et al.  3-Iodothyronamine-A Thyroid Hormone Metabolite With Distinct Target Profiles and Mode of Action. , 2019, Endocrine reviews.

[14]  R. Tomoaia,et al.  Understanding the role of echocardiography in remodeling after acute myocardial infarction and development of heart failure with preserved ejection fraction. , 2019, Medical ultrasonography.

[15]  Anika C. Bundscherer,et al.  Staurosporine induces apoptosis in pancreatic carcinoma cells PaTu 8988t and Panc-1 via the intrinsic signaling pathway , 2019, European Journal of Medical Research.

[16]  A. Harky,et al.  Anti-platelet and anti-coagulant therapy in peripheral arterial disease prior to surgical intervention , 2018, Vascular.

[17]  T. Murohara,et al.  Myonectin Is an Exercise-Induced Myokine That Protects the Heart From Ischemia-Reperfusion Injury , 2018, Circulation research.

[18]  Xianhe Lin,et al.  The novel relationship between Sirt3 and autophagy in myocardial ischemia–reperfusion , 2018, Journal of cellular physiology.

[19]  Huicai Guo,et al.  The regulation of FOXO1 and its role in disease progression. , 2018, Life sciences.

[20]  Yue Jiang,et al.  miR-181a increases FoxO1 acetylation and promotes granulosa cell apoptosis via SIRT1 downregulation , 2017, Cell Death and Disease.

[21]  E. Lucenteforte,et al.  The impact of scopolamine pretreatment on 3-iodothyronamine (T1AM) effects on memory and pain in mice , 2017, Hormones and Behavior.

[22]  B. Yousefi,et al.  The effects of mebudipine on myocardial arrhythmia induced by ischemia-reperfusion injury in isolated rat heart. , 2016, Cellular and molecular biology.

[23]  G. Chiellini,et al.  Update on 3-iodothyronamine and its neurological and metabolic actions , 2014, Front. Physiol..

[24]  T. Scanlan,et al.  Cardioprotective Effect of 3-Iodothyronamine in Perfused Rat Heart Subjected to Ischemia and Reperfusion , 2011, Cardiovascular Drugs and Therapy.

[25]  J. Dias,et al.  Nongenomic signaling pathways triggered by thyroid hormones and their metabolite 3‐iodothyronamine on the cardiovascular system , 2011, Journal of cellular physiology.

[26]  D. Grandy,et al.  Novel Thyroxine Derivatives, Thyronamine and 3-iodothyronamine, Induce Transient Hypothermia and Marked Neuroprotection Against Stroke Injury , 2007, Stroke.